OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Publication Date
Release Date
2022
(3)
2021
(3)
2019
(2)
2023
(1)
2020
(1)
2018
(1)
2014
(1)
2010
(1)
2007
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial.
Not available
S-EPMC4237554
|
biostudies-literature
Cite
Effectiveness and safety of insulin glargine Gla-300 in insulin-naive type 2 diabetes subjects in a real-life setting-the GOAL_RO trial.
Not available
S-EPMC7867914
|
biostudies-literature
Cite
Degradation of alkyl methyl ketones by Pseudomonas veronii MEK700.
Not available
S-EPMC1913341
|
biostudies-literature
Cite
Anti-inflammatory Approach With Early Double Cytokine Blockade (IL-1β and TNF-α) Is Safe and Facilitates Engraftment in Islet Allotransplantation.
Not available
S-EPMC7056279
|
biostudies-literature
Cite
Molecular understanding of sterically controlled compound release through an engineered channel protein (FhuA).
Not available
S-EPMC2909997
|
biostudies-literature
Cite
Biomimetic artificial organelles with in vitro and in vivo activity triggered by reduction in microenvironment.
Not available
S-EPMC5859287
|
biostudies-literature
Cite
Cost Analysis of Liver Acquisition Fees Before and After Acuity Circle Policy Implementation.
Not available
S-EPMC8427489
|
biostudies-literature
Cite
A Worldwide Survey of Activities and Practices in Clinical Islet of Langerhans Transplantation.
Not available
S-EPMC9402897
|
biostudies-literature
Cite
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis.
Not available
S-EPMC10278789
|
biostudies-literature
Cite
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
Not available
S-EPMC6889917
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets